All In Biotech

Drug Trial Radar · NCT06045221

A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy and Safety of Once Daily Oral LY3502970 Compared With Oral Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin (ACHIEVE-3)

Last checked: Nov 20, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,698 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,698

Actual

Start

Sep 22, 2023

Primary completion

Aug 22, 2025

Study completion Aug 22, 2025

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Sep 21, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to assess efficacy and safety of orforglipron compared with oral semaglutide in participants with Type 2 diabetes and inadequate glycemic control with metformin.The study will last around 61 weeks.

Conditions

  • Type 2 Diabetes

Interventions

  • OrforglipronDrug

    Administered orally

  • SemaglutideDrug

    Administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Hemoglobin A1c (HbA1c) [Non-inferiority of 36 mg Orforglipron Versus 14 mg Semaglutide and 12 mg Orforglipron Versus 7 mg Semaglutide]Time frame: Baseline, Week 52

Locations

131 sites in 6 countries. Site status is shown where the registry gives one.

  • Absolute Clinical Research

    Phoenix, Arizona

  • San Fernando Valley Health Institute

    Canoga Park, California

  • Neighborhood Healthcare Institute of Health

    Escondido, California

  • Velocity Clinical Research, Gardena

    Gardena, California

  • Biopharma Informatic, LLC

    Los Angeles, California

  • Velocity Clinical Research, Westlake

    Los Angeles, California

  • Infinity Clinical Research - Norco

    Norco, California

  • Valley Clinical Trials, Inc.

    Northridge, California

  • Norcal Endocrinology & Internal Medicine

    San Ramon, California

  • Encompass Clinical Research

    Spring Valley, California

  • University Clinical Investigators, Inc.

    Tustin, California

  • New West Physicians Clinical Research

    Golden, Colorado

  • Connecticut Clinical Research - Cromwell

    Cromwell, Connecticut

  • Clinical Research of West Florida, Inc. (Clearwater)

    Clearwater, Florida

  • South Florida Clinical Research Institute

    Margate, Florida

  • Miami Dade Medical Research Institute, LLC

    Miami, Florida

  • West Orange Endocrinology

    Ocoee, Florida

  • Latin Clinical Trial Center Florida

    Tamarac, Florida

  • Clinical Research of West Florida

    Tampa, Florida

  • Metabolic Research Institute, Inc.

    West Palm Beach, Florida

  • Balanced Life Health Care Solutions/SKYCRNG

    Lawrenceville, Georgia

  • Clinical Research Atlanta

    Stockbridge, Georgia

  • North Georgia Clinical Research

    Woodstock, Georgia

  • Northwest Clinical Trials

    Boise, Idaho

  • Family First Medical Center

    Idaho Falls, Idaho

  • American Health Network of Indiana, LLC - Greenfield

    Greenfield, Indiana

  • Velocity Clinical Research, Valparaiso

    Valparaiso, Indiana

  • Cotton O'Neil Diabetes & Endocrinology

    Topeka, Kansas

  • Tekton Research, Inc

    Wichita, Kansas

  • DelRicht Research

    New Orleans, Louisiana

  • Joslin Diabetes Center

    Boston, Massachusetts

  • Revival Research Institute, LLC

    Dearborn, Michigan

  • SKY Integrative Medical Center/SKYCRNG

    Ridgeland, Mississippi

  • Kansas City Research Institute

    Kansas City, Missouri

  • Logan Health Research

    Kalispell, Montana

  • Wr-Crcn, Llc

    Las Vegas, Nevada

  • Premier Research

    Trenton, New Jersey

  • Albany Medical College, Division of Community Endocrinology

    Albany, New York

  • Ellipsis Research Group - Brooklyn - 7th Street

    Brooklyn, New York

  • Great Lakes Medical Research, LLC

    Westfield, New York

Showing 40 of 131 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.